MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/clinem/dgaf463

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2025

TSH Cutoffs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis.

Cho Yoon Young, Ahn Soo Hyun, Kim Mijin, Lee Eun Kyung, Park Young Joo, Choi Dughyun, Kim Bo-Yeon, Jung Chan-Hee, Mok Ji Oh, Kim Chul-Hee, Kim Bo Hyun

СтатьяСистематический обзорМетаанализПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

CONTEXT: The current American Thyroid Association (ATA) guidelines recommend tailored TSH suppression, considering the recurrence risk of differentiated thyroid cancer (DTC); however, the evidence is limited.

OBJECTIVE

This meta-analysis aimed to investigate the risk of recurrence in patients with DTC, stratified by the ATA risk of recurrence, according to variable thyrotropin (TSH) cutoffs (0.1, 0.5, and 2.0 mIU/L).

METHODS

We searched Ovid-Medline, EMBASE, and Cochrane databases for studies reporting the recurrence rate of DTCs based on TSH cutoffs through March 2024. The search terms used included "thyroid neoplasm" OR "cancer," "TSH" OR "thyroid stimulating hormone," "suppress" OR "supplementation," and "thyroidectomy".

RESULTS

Two randomized controlled trials and 7 observational studies, including 5320 patients, were analyzed, with an overall recurrence rate of 18%. The pooled recurrence risk for DTCs at each TSH cutoff (0.1, 0.5, and 2.0 mIU/L) was not significant. In the subgroup analysis, the pooled hazard ratios (HRs) stratified by the ATA risk of recurrence (low- and high-risk DTCs) did not differ according to TSH levels. However, the risks of recurrence increased at serum TSH of 0.1 mIU/L or greater (HR 2.27; 95% CI, 1.29-3.99) and TSH of 2.0 mIU/L or greater (HR 1.36; 95% CI, 1.001-1.84) in a leave-one-out meta-analysis after removing the study that significantly influenced the analysis. Patients with distant metastases had a higher risk of recurrence (HR 3.3; 95% CI, 1.53-7.10) when maintaining a TSH greater than or equal to 0.1 mIU/L.

CONCLUSION

The degree of TSH suppression did not affect the overall risk of DTC recurrence. However, TSH suppression may be beneficial in reducing the recurrence risk in high-risk patients with distant metastases.

Для цитирования: Cho Yoon Young, Ahn Soo Hyun, Kim Mijin, Lee Eun Kyung, Park Young Joo, Choi Dughyun, Kim Bo-Yeon, Jung Chan-Hee, Mok Ji Oh, Kim Chul-Hee, Kim Bo Hyun. TSH Cutoffs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis.. The Journal of clinical endocrinology and metabolism. 2025. DOI: 10.1210/clinem/dgaf463.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.